Hepatic Pseudoprogression after Treatment with Nectin-4–Targeted Antibody–Drug Conjugate
New England Journal of Medicine · 16.04.2026 · 394 (15) · 1548-1549
DOI: 10.1056/nejmc2518316 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 16.04.2026. Verfasst von Shanbing Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Second People's Hospital of Yibin, Yibin, China. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Second People's Hospital of Yibin, Yibin, China.
Zitieren
APA
Wang, S., Liu, J., & Xie, F. (2026). Hepatic Pseudoprogression after Treatment with Nectin-4–Targeted Antibody–Drug Conjugate. New England Journal of Medicine, 394(15), 1548-1549. https://doi.org/10.1056/nejmc2518316
Vancouver
Wang S, Liu J, Xie F. Hepatic Pseudoprogression after Treatment with Nectin-4–Targeted Antibody–Drug Conjugate. New England Journal of Medicine. 2026;394(15):1548-1549. doi:10.1056/nejmc2518316
BibTeX
@article{Wang2026,
author = {Wang, Shanbing and Liu, Jiapei and Xie, Fang},
title = {Hepatic Pseudoprogression after Treatment with Nectin-4–Targeted Antibody–Drug Conjugate},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {15},
pages = {1548--1549},
doi = {10.1056/nejmc2518316}
}
EUVIMED